Goodwin Procter·FDA / LIFE SCIENCES REGULATORY
Delaware Court Grants Janssen Preliminary Injunction Against Golimumab Biosimilar
A U.S. District Court for the District of Delaware granted Janssen a preliminary injunction on September 30, 2026, barring a competing golimumab biosimilar from launch pending further proceedings.
biosimilarpreliminary-injunctiondelawaregolimumabjanssenbiosimilar-litigation
Read the original firm alert → Wednesday, October 7, 2026